Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis
- PMID: 25169503
- DOI: 10.7314/apjcp.2014.15.16.6649
Fenofibrate increases radiosensitivity in head and neck squamous cell carcinoma via inducing G2/M arrest and apoptosis
Abstract
Radiation therapy is an important treatment for head and neck squamous cell carcinoma (HNSCC). However, how to promote radiation sensitivity in HNSCC remains a challenge. This study aimed to investigate the radiosensitizing effects of fenofibrate on HNSCC and explore the underlying mechanisms. HNSCC cell lines CNE-2 and KB were subjected to ionizing radiation (IR), in the presence or absence of fenofibrate treatment. Cell growth and survival, apoptosis and cell cycle were evaluated. In addition, CNE-2 cells were xenografted into nude mice and subjected to IR and/ or fenofibrate treatment. The expression of cyclinB and CDK1 was detected by Western blotting. Our results showed that fenofibrate efficiently radiosensitized HNSCC cells and xenografts in mice, and induced apoptosis and G2/M arrest via reducing the activity of the CDK1/cyclinB1 kinase complex. These data suggest that fenofibrate could be a promising radiosensitizer for HNSCC radiotherapy.
Similar articles
-
Study on the sensitizing effect of SM-1 combined with irradiation on head and neck squamous cell carcinoma.Int J Radiat Biol. 2024;100(10):1453-1461. doi: 10.1080/09553002.2024.2381490. Epub 2024 Aug 13. Int J Radiat Biol. 2024. PMID: 39136543
-
Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Oncotarget. 2017 Mar 28;8(13):20961-20973. doi: 10.18632/oncotarget.15468. Oncotarget. 2017. PMID: 28423495 Free PMC article.
-
Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.Clin Cancer Res. 2016 Apr 15;22(8):2009-19. doi: 10.1158/1078-0432.CCR-15-2245. Epub 2015 Nov 20. Clin Cancer Res. 2016. PMID: 26589432 Free PMC article.
-
Overcoming radioresistance in head and neck squamous cell carcinoma.Oral Oncol. 2016 Dec;63:44-51. doi: 10.1016/j.oraloncology.2016.11.002. Epub 2016 Nov 15. Oral Oncol. 2016. PMID: 27938999 Review.
-
Potential methods for predicting tumor radiocurability.Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):459-67. doi: 10.1016/0360-3016(86)90053-2. Int J Radiat Oncol Biol Phys. 1986. PMID: 3516949 Review.
Cited by
-
Identification of potential core genes and pathways predicting pathogenesis in head and neck squamous cell carcinoma.Biosci Rep. 2021 May 28;41(5):BSR20204148. doi: 10.1042/BSR20204148. Biosci Rep. 2021. PMID: 33982750 Free PMC article.
-
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.Front Oncol. 2021 May 10;11:653621. doi: 10.3389/fonc.2021.653621. eCollection 2021. Front Oncol. 2021. PMID: 34041023 Free PMC article. Review.
-
Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro.Sci Rep. 2019 Apr 19;9(1):6316. doi: 10.1038/s41598-019-42838-y. Sci Rep. 2019. PMID: 31004117 Free PMC article.
-
Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.J Cancer. 2020 Jul 20;11(19):5556-5567. doi: 10.7150/jca.39888. eCollection 2020. J Cancer. 2020. PMID: 32913451 Free PMC article.
-
Lipid-lowering drugs and cancer: an updated perspective.Pharmacol Rep. 2024 Feb;76(1):1-24. doi: 10.1007/s43440-023-00553-6. Epub 2023 Nov 28. Pharmacol Rep. 2024. PMID: 38015371 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous